How Can We Improve the Management of Patients with Hypertension?

被引：2
|
作者：
Alpert, Joseph S. [1 ]
机构：
[1] Univ Arizona, Coll Med, Tucson, AZ 85724 USA
来源：
AMERICAN JOURNAL OF MEDICINE | 2017年 / 130卷 / 01期
关键词：
BLOOD-PRESSURE; RANDOMIZED-TRIAL;
D O I：
10.1016/j.amjmed.2016.08.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] Cardiovascular risks specificities in the women: how can we improve the management?
    Mounier-Vehier, Claire
    Delsart, Pascal
    Letombe, Brigitte
    PRESSE MEDICALE, 2010, 39 (02): : 234 - 241
  • [2] How Can We Improve Outcomes Assessment?
    Chalmers, Peter N.
    Verma, Nikhil N.
    ORTHOPEDICS, 2015, 38 (10) : 594 - 596
  • [3] How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations
    Solmi, Marco
    Miola, Alessandro
    Croatto, Giovanni
    Pigato, Giorgio
    Favaro, Angela
    Fornaro, Michele
    Berk, Michael
    Smith, Lee
    Quevedo, Joao
    Maes, Michael
    Correll, Christoph U.
    Carvalho, Andre F.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2021, 43 (02) : 189 - 202
  • [4] How can we improve clinical trials in amyotrophic lateral sclerosis?
    Gordon, Paul H.
    Meininger, Vincent
    NATURE REVIEWS NEUROLOGY, 2011, 7 (11) : 650 - 654
  • [5] Antidepressant medication can improve hypertension in elderly patients with depression
    Fu, Wenjing
    Ma, Lina
    Zhao, Xiaoling
    Li, Yun
    Zhu, Hong
    Yang, Wei
    Liu, Chuan
    Liu, Jia
    Han, Rui
    Liu, Huizhen
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (12) : 1911 - 1915
  • [6] A Framework for Discussion on How to Improve Prevention, Management, and Control of Hypertension in Canada
    Campbell, Norm
    Young, Eric R.
    Drouin, Denis
    Legowski, Barbara
    Adams, Michael A.
    Farrell, Judi
    Kaczorowski, Janusz
    Lewanczuk, Richard
    Lum-Kwong, Margaret Moy
    Tobe, Sheldon
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (03) : 262 - 269
  • [7] How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
    Laverty, H. G.
    Benson, C.
    Cartwright, E. J.
    Cross, M. J.
    Garland, C.
    Hammond, T.
    Holloway, C.
    McMahon, N.
    Milligan, J.
    Park, B. K.
    Pirmohamed, M.
    Pollard, C.
    Radford, J.
    Roome, N.
    Sager, P.
    Singh, S.
    Suter, T.
    Suter, W.
    Trafford, A.
    Volders, P. G. A.
    Wallis, R.
    Weaver, R.
    York, M.
    Valentin, J. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (04) : 675 - 693
  • [8] Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged sword
    Azizi, Michel
    Monge, Matthieu
    Lorthioir, Aurelien
    Bobrie, Guillaume
    Amar, Laurence
    JOURNAL OF HYPERTENSION, 2013, 31 (10) : 1948 - 1951
  • [9] Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?
    Theodorakopoulou, Marieta
    Ortiz, Alberto
    Fernandez-Fernandez, Beatriz
    Kanbay, Mehmet
    Minutolo, Roberto
    Sarafidis, Pantelis A.
    CLINICAL KIDNEY JOURNAL, 2024, 17 : 36 - 50
  • [10] Can we improve outcome of congenital diaphragmatic hernia?
    van den Hout, L.
    Sluiter, I.
    Gischler, S.
    De Klein, A.
    Rottier, R.
    Ijsselstijn, H.
    Reiss, I.
    Tibboel, D.
    PEDIATRIC SURGERY INTERNATIONAL, 2009, 25 (09) : 733 - 743
12345